Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico by unknown
RESEARCH ARTICLE Open Access
Seroepidemiology of cytomegalovirus infection in
pregnant women in Durango City, Mexico
Cosme Alvarado-Esquivel1*, Jesús Hernández-Tinoco2, Luis Francisco Sánchez-Anguiano2, Agar Ramos-Nevárez3,
Sandra Margarita Cerrillo-Soto3, Sergio Estrada-Martínez2, Lucio Martínez-Ramírez3, Alma Rosa Pérez-Álamos2
and Carlos Alberto Guido-Arreola3
Abstract
Background: Cytomegalovirus causes congenital infections all around the world. The seroepidemiology of
cytomegalovirus infection in pregnant women in Mexico is largely unknown. We sought to determine the
seroprevalence of cytomegalovirus infection in pregnant women in Durango City, Mexico; and to determine
seroprevalence association with socio-demographic, clinical and behavioral characteristics of pregnant women.
Methods: Through a cross-sectional study design, 343 pregnant women were examined for anti-cytomegalovirus IgG
and IgM antibodies in Durango City, Mexico. We used a standardized questionnaire to obtain the general characteristics
of the pregnant women. Multivariate analysis was performed to determine the association of cytomegalovirus infection
with the characteristics of the pregnant women.
Results: Anti-CMV IgG and IgM antibodies were detected in 225 (65.6%) and in none of the 343 pregnant women
studied, respectively. Multivariate analysis showed that CMV exposure was associated with increasing age (OR = 1.67;
95% CI: 1.01-2.76; P = 0.04). Other women characteristics including socioeconomic status, education, blood transfusion,
transplantation, sexual promiscuity and number of previous pregnancies or deliveries did not show an association with
CMV exposure.
Conclusions: This is the first seroepidemiology study of CMV infection in pregnant women in Mexico. A number of
known factors associated with CMV infection were not associated with CMV exposure in the women studied. Further
studies to determine routes of CMV infection in pregnant women in Mexico are needed.
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Background
Cytomegalovirus (CMV) is a DNA virus of the Betaher-
pesvirinae subfamily and Herpesviridae family [1]. CMV
is a leading cause of congenital infections all around the
world [2-4]. Congenital infections with CMV may be
asymptomatic [5] or may lead to hearing impairment,
mental retardation, cerebral palsy [6], and neurodevelop-
mental disabilities [2,4]. The incidence of congenital
CMV infection is about 1%-7% of births [4]. In addition,
congenital CMV infection may occur not only in primary
but also in non-primary maternal infections [4]. Infections
with CMV persist through chronic and latent states
of infections [7], and can be reactivated with shedding
of infectious virus [1,8]. Transmission of CMV occurs by
person-to-person contact [1]. In addition, CMV infection
acquired by blood transfusion may lead to significant
complications in immunocompromised individuals [9].
Severe disease including pneumonia, retinitis, hepatitis,
encephalitis, and other organ involvements due to CMV
in immunocompromised patients have been reported [10].
Very little is known about the seroepidemiology of
CMV infection in Mexican populations. We are not
aware of any study on the seroepidemiology of CMV
infection in pregnant women in Mexico. Therefore,
we sought to determine the seroprevalence of CMV
infection in pregnant women in Durango City, Mexico. In
addition, the socio-demographic, clinical and behavioral
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characteristics of pregnant women associated with CMV
infection were also investigated.
Methods
Study population and study design
Through a cross-sectional study design, we studied
pregnant women in a public primary health care center
(Clínica de Medicina Familiar, Instituto de Seguridad y
Servicios Sociales de los Trabajadores del Estado) in
Durango City, Mexico from April to November 2013.
Inclusion criteria for enrollment in the study were: 1)
pregnant women; 2) residing in Durango City; 3) aged
15 years and older; and 4) who accepted to participate in
the study.
Socio-demographic, clinical and behavioral data
We submitted a standardized questionnaire to obtain
socio-demographic, clinical and behavioral characteristics
from the pregnant women studied. Socio-demographic
data included age, birthplace, residence, occupation, and
educational and socio-economic status. Clinical data
included obstetric history (month of pregnancy, number of
pregnancies, deliveries, cesarean sections and miscarriages),
presence of any underlying disease, history of lymphaden-
opathy, frequent headaches and impairments of memory,
reflexes, vision and hearing, and history of hepatitis, blood
transfusions, transplants or surgery. Behavioral data
included addictions, sexual promiscuity, washing hands
before eating, eating away of home (in restaurants
and fast food outlets), consumption of unpasteurized
milk, untreated water, and unwashed raw vegetables
or fruits, foreign travel, and type of flooring at home.
Laboratory tests
Serum samples were obtained from each pregnant
women by centrifugation of whole blood. Sera of the
women were kept frozen until analyzed. Sera were
examined for anti-CMV IgG antibodies by a commercially
available enzyme immunoassay “Cytomegalovirus IgG
(CMV IgG)” kit (Diagnostic Automation Inc., Calabasas,
CA, USA) and for anti-CMV IgM antibodies by a com-
mercially available enzyme immunoassay “Cytomegalo-
virus IgM (CMV IgM” kit (Diagnostic Automation Inc.,
Calabasas, CA, USA). The tests were performed following
the instructions of the manufacturer. The cut-off
values for IgG and IgM seropositivity were obtained
as follows: firstly, the mean optical densities of IgG
and IgM calibrators were multiplied by the correction
factor (0.50-0.55) printed on the label of calibrators
to obtained the corrected mean cut-off value: then,
we calculated the CMV G and M indexes by dividing
the optical density of each sample by the corrected
mean cut-off value. A sample was considered positive for
IgG or IgM when a CMV G index or a CMV M index was
greater than 1.1, respectively. These assays are qualitative,
and no quantification of antibody levels were performed.
Ethical aspects
This study was approved by the ethical committee of
the Instituto de Seguridad y Servicios Sociales de los
Trabajadores del Estado in Durango City. The purpose and
procedures of the study were explained to all pregnant
women, and a written informed consent was obtained from
all of them and from the next of kin of minor participants.
Statistical analysis
The statistical analysis was performed with the aid of the
software: Epi Info version 7 and SPSS version 15.0. For
calculation of the sample size, we used a value of 15,000
as a population size from which the sample was selected, a
reference seroprevalence of 89.2% [11] as expected fre-
quency of the factor under study, 3.5% of confidence limits,
a design effect of 1.0, one cluster, and a confidence level of
95%. The result of the calculation was 296 subjects. We
used the Pearson’s chi square and the Fisher exact test
(when values were small) for comparison of the frequencies
among groups. Bivariate and multivariate analyses were
used to evaluate the association between the characteristics
of the women and CMV seropositivity. Variables with
a P value equal to or less than 0.10 obtained in the bivariate
analysis were included in the multivariate analysis. Odd
ratios (OR) and 95% confidence intervals (CI) were
calculated by multivariate analysis using the Enter method. A
P value less than 0.05 was considered statistically significant.
Results
In total, we enrolled 343 pregnant women. Most of them
were born in Durango; their mean age was 28.88 ± 6.12 years
(range 15–43 years). General socio-demographic and obstet-
ric characteristics of the pregnant women studied are shown
in Table 1. Anti-CMV IgG antibodies were detected in 225
(65.6%) of the 343 pregnant women studied. None of the
343 pregnant women had anti-CMV IgM antibodies.
Of the socio-demographic characteristics of the
pregnant women (Table 1), only the variable age
showed a P value <0.10 by bivariate analysis. Other
socio-demographic characteristics including birthplace,
residence, educational level, occupation and socio-economic
status had P values >0.10 by bivariate analysis.
With respect to behavioral characteristics, smoking was
the only variable that showed a P value <0.10 by bivariate
analysis. Other behavioral characteristics including foreign
travel, eating away of home, consumption of untreated
water, and unwashed raw vegetables or fruits, drug or alco-
hol addictions, sexual promiscuity, washing hands before
eating, and type of flooring at home show P values >0.10 by
bivariate analysis.
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Concerning clinical characteristics, seroprevalence of
CMV infection was similar in ill (7/15: 46.7%) than in
healthy (217/327: 66.4%) pregnant women (P = 0.11).
In contrast, seroprevalence of CMV infection was
significantly higher (P = 0.04) in pregnant women with
history of lymphadenopathy (39/50: 78.0%) than in
those without such history (186/292: 63.7%). Pregnant
women with more than two pregnancies had a signifi-
cantly higher (P = 0.04) seroprevalence of CMV exposure
(158/228: 69.3%) than those with one or two pregnancies
(67/115: 58.3%). Other clinical characteristics of pregnant
women including impairments of memory, reflexes,
vision and hearing, history of hepatitis, blood transfusions,
transplants or surgery, and other obstetric characteristics
(month of pregnancy, number of deliveries, cesarean
sections and miscarriages) were not associated with
CMV infection.
Multivariate analysis of socio-demographic, clinical
and behavioral variables with P values equal to or lower
than 0.10 by bivariate analysis (Table 2) showed that
CMV infection was positively associated only with age
(OR = 1.67; 95% CI: 1.01-2.76; P = 0.04).
Discussion
There is a lack of knowledge about the epidemiology of
CMV infection in pregnant women in Mexico. The present
study was performed to investigate the seroprevalence and
correlates of CMV infection in pregnant women in the
northern Mexican city of Durango. We found a 65.6%
seroprevalence of CMV infection in the pregnant women
studied. Based on the seropositivity to CMV IgG and IgM
antibodies, all women with CMV exposure had latent
infection and none had recent or acute CMV infection.
We are not aware of previous reports about the seroepide-
miology of CMV infection in pregnant women in Mexico.
Therefore, we cannot compare our seroprevalence results
with others in pregnant women in Mexico. In a study in
healthy women of reproductive age in Cuernavaca City in
central Mexico, researchers found a 92.6% seroprevalence
of CMV infection [12]. While in a national survey in sub-
jects aged 1 to 70 years old in Mexico an 88.2% seropreva-
lence of CMV infection was found [11]. On the other hand,
comparison of our seroprevalence with those reported in
Table 1 Socio-demographic and obstetric characteristics






Characteristic testeda No. %
Age groups (years)
15-30 198 119 60.1 0.009
31-43 144 106 73.6
Birth place
Durango State 319 209 65.5 0.68
Other Mexican State 20 14 70.0
Residence place
Durango State 342 224 65.5 1.00
Other Mexican State 1 1 100.0
Residence area
Urban 325 213 65.5 0.75
Suburban 5 4 80.0
Rural 13 8 61.5
Educational level
Up to 6 years 1 1 100.0 0.75
7-12 years 133 88 66.2
13 or more years 209 136 65.1
Occupation
Unemployedb 110 69 62.7 0.44
Employedc 233 156 67.0
Socio-economic level
Low 19 14 73.7 0.69
Medium 316 206 62.5
High 4 3 75.0
Month of pregnancy
1 to 3 117 77 65.8 0.91
4 to 6 153 100 65.4
7 to 9 66 45 68.2
Deliveries
Yes 140 94 67.1 0.59
No 202 130 64.4
Pregnancies
3 or more 228 158 69.3 0.04
1 or 2 115 67 58.3
Cesarean sections
None 241 155 64.3 0.47
1 or 2 101 69 68.3
Miscarriages
None 269 173 64.7 0.37
1-3 73 51 69.9
aPregnant women with available data.
bUnemployed = none occupation, student or housewife.
cEmployed = Employee, professional, business, or other.
Table 2 Multivariate analysis of selected characteristics of
pregnant women and their association with CMV infection
Characteristic Odds ratioa 95% confidence
interval
P value
Age (31–43 years) 1.67 1.01 - 2.76 0.04
Lymphadenopathy 2.03 0.98 - 4.19 0.05
More than 2 pregnancies 1.36 0.81 - 2.26 0.23
Smoking 0.53 0.26 - 1.07 0.08
aAdjusted by the characteristics included in this Table.
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other countries suggests that the seroprevalence of CMV
infection in pregnant women in Durango could be placed
in an intermediate position of endemicity. The 65.6% sero-
prevalence found in pregnant women in Durango is similar
to the 62.4%-66% seroprevalences reported in pregnant
women in Poland [13], Japan [14], and Norway [15], and
higher than the 49% seroprevalence in white British
pregnant women in the United Kingdom [16] and a 42.3%
seroprevalence in pregnant women in Germany [17]. In
contrast, the seroprevalence found in pregnant women in
Durango is lower than the 92.6%-100% seroprevalences
reported in pregnant women in Iran [18], Palestine [19],
Brazil [20], Turkey [21], Nigeria [22], and Cuba [23].
Analysis of the socio-demographic characteristics showed
that the seroprevalence of CMV infection in pregnant
women increased with age. This finding is consistent with
those reported in other studies where researchers found an
increase in the seroprevalence of CMV infection with age
in both pregnant women [13] and general population [24].
Other known contributing factors for CMV infection
including socioeconomic status [8], education, sexual
promiscuity [12], blood transfusion and transplantation
[25] did not show any association with CMV exposure in
the women studied. Of the sources of infection with CMV
in pregnant women stands out young children [26,27]. We
assess the contact with young children by evaluating the
number of children the women have already born (history
of pregnancies), considering that women with more than
two pregnancies had a higher contact with children than
women with fewer pregnancies. Analysis showed that
women with more than two pregnancies had a higher,
but not statistically significant, seroprevalence of CMV
infection than those with one or two pregnancies. This
approach was a limitation of the study since contact with
children can occur not only at home but also at work in
some women. In the present study, the occupation of
housewife was not associated with CMV exposure. None
of the pregnant women studied reported to be school-
teacher or baby-sitter and the lack of these occupations
among the studied women might have a negative influence
on the seroprevalence. Therefore, the association of CMV
exposure with contact with children should be further
evaluated in pregnant women in Mexico. Hygiene practices
are important in the prevention of CMV infection [26].
However, in this study the variable washing hands before
eating did not show an association with CMV exposure.
Conclusions
This is the first seroepidemiology study of CMV infection
in pregnant women in Mexico. A number of known
factors associated with CMV infection were not associated
with CMV exposure in the women studied. Further studies
to determine routes of CMV infection in pregnant women
in Mexico are needed.
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